Plain-English translation of NCT07054125 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a program called COMPASS that combines continuous glucose monitoring (a small device that tracks your blood sugar throughout the day) with virtual group visits. In these group visits, you'll learn how to use the glucose monitor, discuss nutrition, movement, stress management, and other strategies to help bring your blood sugar levels down to a healthier range.
Many people with type 2 diabetes struggle to get their blood sugar under control with standard care alone. This study is designed to see whether combining real-time glucose tracking with group education and peer support can help people achieve better blood sugar control and improve their overall quality of life.
You likely qualify if…
You likely don't qualify if…
You will wear a continuous glucose monitor (a small sensor on your skin) that tracks your blood sugar in real time. You'll join virtual group visits to learn how to understand your glucose readings and discuss strategies for managing your diabetes, such as food choices, physical activity, and stress relief. The study will help you and your healthcare team work together to reach healthier blood sugar levels.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States
Sponsor
Whole Endo
Collaborators
DexCom, Inc.
Enrollment target
~100 participants
Started
August 2025
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rashim Gupta, MD
Whole Endo
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.